Evidence for an early interaction of the RANKL pathway and mesenchymal stromal cells in bone marrow of patients with localized prostate cancer

被引：0
|
作者：
Todenhoefer, T. [1 ]
Hennenlotter, J. [1 ]
Hohneder, A. [1 ]
Grimm, S. [2 ]
Schmiedel, B. [2 ]
Buehring, H. J. [2 ]
Gakis, G. [1 ]
Stenzl, A. [1 ]
Schwentner, C. [1 ]
机构：
[1] Univ Tubingen, Dept Urol, Tubingen, Germany
[2] Univ Tubingen, Dept Hematol & Oncol, Tubingen, Germany
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2012年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E651 / U394
页数：2
相关论文
共 50 条
  • [1] Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases
    Todenhoefer, Tilman
    Hennenlotter, Joerg
    Schmiedel, Benjamin Joachim
    Hohneder, Andrea
    Grimm, Sabrina
    Kuehs, Ursula
    Salih, Helmut Rainer
    Buehring, Hans-Joerg
    Fehm, Tanja
    Gakis, Georgios
    Blumenstock, Gunnar
    Aufderklamm, Stefan
    Schilling, David
    Stenzl, Arnulf
    Schwentner, Christian
    PROSTATE, 2013, 73 (02): : 162 - 168
  • [2] Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer
    Bianco, FJ
    Wood, DP
    de Oliveira, JG
    Nemeth, JA
    Beaman, AA
    Cher, ML
    PROSTATE, 2001, 49 (04): : 235 - 242
  • [3] BMPRIA is required for osteogenic differentiation and RANKL expression in adult bone marrow mesenchymal stromal cells
    Soma Biswas
    Ping Li
    Hongguang Wu
    Md Shafiquzzaman
    Shunichi Murakami
    Michael D. Schneider
    Yuji Mishina
    Baojie Li
    Jing Li
    Scientific Reports, 8
  • [4] BMPRIA is required for osteogenic differentiation and RANKL expression in adult bone marrow mesenchymal stromal cells
    Biswas, Soma
    Li, Ping
    Wu, Hongguang
    Shafiquzzaman, Md
    Murakami, Shunichi
    Schneider, Michael D.
    Mishina, Yuji
    Li, Baojie
    Li, Jing
    SCIENTIFIC REPORTS, 2018, 8
  • [5] Characteristics of bone marrow mesenchymal stromal cells in patients with hematological malignancies
    Shevela, E. Ya.
    Petrovsky, Ya. L.
    Kurganova, E. V.
    Tikhonova, M. A.
    Sakhno, L. V.
    Sergeyevicheva, V. V.
    Kulagin, A. D.
    Lisukov, I. A.
    Ostanin, A. A.
    Chernykh, E. R.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2008, 53 (02): : 32 - 37
  • [6] Evidences of Early Senescence in Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells
    Andre, Thibaud
    Meuleman, Nathalie
    Stamatopoulos, Basile
    De Bruyn, Cecile
    Pieters, Karlien
    Bron, Dominique
    Lagneaux, Laurence
    PLOS ONE, 2013, 8 (03):
  • [7] Bone marrow stromal cells promote growth and survival of prostate cancer cells
    Cross, N. A.
    Papageorgiou, M.
    Eaton, C. L.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 698 - 700
  • [8] Cellular proliferation and prevalence of micrometastatic cells in the bone marrow of patients with clinically localized prostate cancer
    Cher, ML
    de Oliveira, JG
    Beaman, AA
    Nemeth, JA
    Hussain, M
    Wood, DP
    CLINICAL CANCER RESEARCH, 1999, 5 (09) : 2421 - 2425
  • [9] The prognostic impact of cytokeratin-positive cells in bone marrow of patients with localized prostate cancer
    Lilleby, W
    Nesland, JN
    Fossa, SD
    Torlakovic, G
    Waehre, H
    Kvalhem, G
    INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (01) : 91 - 96
  • [10] Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer
    Cackowski, Frank C.
    Wang, Yugang
    Decker, Joseph T.
    Sifuentes, Christopher
    Weindorf, Steven
    Jung, Younghun
    Wang, Yu
    Decker, Ann M.
    Yumoto, Kenji
    Szerlip, Nicholas
    Buttitta, Laura
    Pienta, Kenneth J.
    Morgan, Todd M.
    Taichman, Russell S.
    PROSTATE, 2019, 79 (14): : 1715 - 1727
12345